CongenPharma EMPHASES® that the new liquid-phase peptide synthesis platform has secured another invention patent, bringing the total number of patents in China, the U.S., and Japan to 8!
Publish Time:
2025-10-29
CongenPharma’s pioneering EMPHASES novel liquid-phase peptide synthesis platform has secured another invention patent, bringing its total number of patents in China, the U.S., and Japan to 8. The company’s second-generation carrier leads the industry with its superior features—better stability, enhanced solubility, shorter reaction steps, and lower costs—enabling higher yields in peptide synthesis!
Relevant Information
undefined
